ClinicalTrials.Veeva

Menu
S

Sleep Therapy and Research Center | Medical Center Drive Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-861
ADX-N05
E2086
Armodafinil

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime...

Enrolling
Narcolepsy Type 1 (NT1)
Drug: Active Comparator Placebo
Drug: E2086 Placebo

Trial sponsors

Takeda logo
Philips logo
V
A
C
D
Eisai logo
I
Jazz Pharmaceuticals logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems